Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (HLTC) EBIT (2016 - 2025)

Historic EBIT for National Healthcare Properties (HLTC) over the last 13 years, with Q3 2025 value amounting to $2.4 million.

  • National Healthcare Properties' EBIT rose 11134.95% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 10683.84%. This contributed to the annual value of -$123.5 million for FY2024, which is 250745.04% down from last year.
  • Per National Healthcare Properties' latest filing, its EBIT stood at $2.4 million for Q3 2025, which was up 11134.95% from -$5.5 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' EBIT registered a high of $13.0 million during Q1 2025, and its lowest value of -$100.4 million during Q2 2024.
  • Its 5-year average for EBIT is -$9.9 million, with a median of -$4.7 million in 2022.
  • As far as peak fluctuations go, National Healthcare Properties' EBIT crashed by 1245424.35% in 2024, and later skyrocketed by 126285.71% in 2025.
  • Quarter analysis of 5 years shows National Healthcare Properties' EBIT stood at -$7.6 million in 2021, then skyrocketed by 38.59% to -$4.7 million in 2022, then plummeted by 41.42% to -$6.6 million in 2023, then soared by 83.96% to -$1.1 million in 2024, then skyrocketed by 325.12% to $2.4 million in 2025.
  • Its EBIT was $2.4 million in Q3 2025, compared to -$5.5 million in Q2 2025 and $13.0 million in Q1 2025.